This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Rutgers, The State University of New Jersey. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New Brunswick, NJ (US) (2021)
- Piscataway, NJ (US) (2023)
Company Filing History:
Years Active: 2021-2025
Title: Adam Gormley: Innovator in Polymer Science
Introduction
Adam Gormley is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of polymer science, particularly in the area of biocompatible materials for medical applications. With a total of 3 patents, Gormley's work focuses on innovative methods for targeted delivery of therapeutic agents.
Latest Patents
Gormley's latest patents include groundbreaking inventions. One of his patents, titled "In vivo radical-mediated polymerization for targeted delivery of trophic factors," presents a biocompatible conjugate designed for treating diseases or injuries. This conjugate features a polymer that is covalently linked to moieties containing polymerizable functional groups. Upon exposure to elevated levels of free radicals associated with a disease or injury, the conjugate forms a cross-linked polymer network.
Another significant patent is "Derivatizable monomers and polymers, and methods for making and using same." This invention introduces UV-sensitive monomers that include a cyclopropenone-containing group, which acts as a masked dibenzocyclooctyne (DBCO)/dibenzoazocyclooctyne (DIBAC) group. These monomers can be polymerized using reversible addition fragmentation chain transfer (RAFT) polymerization techniques, resulting in a polymer that contains the masked DBCO/DIBAC group. Under controlled conditions, the DBCO/DIBAC group can be unmasked, allowing for the conjugation of small molecules and macromolecules to the polymer through highly selective and efficient strain-promoted azide alkyne click chemistry (SPAAC).
Career Highlights
Adam Gormley is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research in polymer science. His work has garnered attention for its potential applications in medical treatments and drug delivery systems.
Collaborations
Gormley collaborates with esteemed colleagues, including Christopher Lowe and David I Shreiber. Their combined expertise enhances the innovative research being conducted at Rutgers.
Conclusion
Adam Gormley's contributions to polymer science and his innovative patents reflect his commitment to advancing medical technology. His work continues to pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile